Results 21 to 30 of about 3,570 (199)
Effectiveness of Duloxetine for Postsurgical Chronic Neuropathic Disorders after Spine and Spinal Cord Surgery [PDF]
Asian Spine Journal, 2021 Study Design This is a retrospective observational study with an outpatient setting. Purpose This study aimed to describe the effects of duloxetine (DLX) administration for postsurgical chronic neuropathic disorders (both pain and numbness) following ...
Osahiio Tsuji +10 more
doaj +1 more source
Royal Society Open Science, 2021 Duloxetine is an antidepressant that exhibits its action by preventing the reuptake of serotonin and norepinephrine by neurons. In this analytical study, we developed two facile, sensitive methods for duloxetine analysis.
Sayed M. Derayea +2 more
doaj +1 more source
Asian Journal of Chemistry, 2023 The nitrosamine family of chemicals is a large group of carcinogens found in human diets and other environmental media. In animal experiments, it has been shown that N-nitroso compounds can cause cancer, hence the presence of nitrosamine impurities are important to evaluate and need to be quantified.
PERLA GANESH +6 more
openaire +1 more source
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy [PDF]
Diabetes & Metabolism Journal, 2023 Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of diabetes. The lifetime prevalence of DPN is thought to be >50%, and 15%–25% of patients with diabetes experience neuropathic pain, referred to as “painful DPN ...
Han Na Jang, Tae Jung Oh
doaj +1 more source
International Journal of Polymer Science, 2021 The purpose of the research was to optimize the preparation of duloxetine hydrochloride (duloxetine HCl) delayed release tablets. Duloxetine HCl produces a toxic substance called alpha-naphthol when duloxetine HCl is in contact with gastric fluid.
M. Yasmin Begum +6 more
doaj +1 more source
Preclinical discovery of duloxetine for the treatment of depression [PDF]
, 2012 Introduction: Affective disorders, including major depressive disorder (MDD), are among the most severely disabling mental disorders, and in many cases areIntroduction: Affective disorders, including major depressive disorder (MDD), are among the most ...
Berrocoso Domínguez, Esther María +4 more
core +2 more sources
DULOXETINE HYDROCHLORIDE INDUCED PARESTHESIA - A CASE REPORT
Asian Journal of Pharmaceutical and Clinical Research, 2023 A 45-year-old HIV-positive female patient experienced a generalized burning sensation after the administration of one dose of duloxetine 20 mg. The patient’s concurrent medications include a fixed drug combination of nevirapine 200 mg, Lamivudine 150 mg, and Zidovudine 300 mg, twice daily for 5 years.
SAI PAWAN AR +2 more
openaire +1 more source
Data mining techniques applied in the analysis of historical data [PDF]
Arhiv za farmaciju, 2022 Understanding the effect of the characteristics of formulation and process parameters on the physicochemical properties of a pharmaceutical product is very significant for the development of solid dosage forms, as the knowledge gained on small scale ...
Kovačević Jovana +4 more
doaj +1 more source
Serotonin syndrome in a patient with chronic pain taking analgesic drugs mistaken for psychogenic nonepileptic seizure: a case report [PDF]
Yeungnam University Journal of Medicine, 2021 Serotonin syndrome (SS) is a potentially life-threatening condition that is caused by the administration of drugs that increase serotonergic activity in the central nervous system. We report a case of serotonin syndrome in a patient with chronic pain who
Mathieu Boudier-Revéret +1 more
doaj +1 more source
A survey of Top 200 Drugs—Inconsistent Practice of Drug Strength Expression for Drugs Containing Salt Forms [PDF]
, 2012 Many ionizable drugs are developed and marketed as salt forms. However, there are no clear US regulatory guidelines on drug strength labeling for salts. The strengths of some drugs are expressed as salts and some as free acids/bases.
Prohotsky, Daniel, Zhao, Fang
core +2 more sources